![Mayukh Sukhatme](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mayukh Sukhatme
President chez
ROIVANT SCIENCES LTD.
Fortune : 559 M $ au 31/05/2026
Profil
Actuellement, Mayukh Sukhatme occupe le poste de coprésident et directeur des investissements chez Roivant Sciences Ltd, coprésident et directeur des investissements chez Roivant Sciences GmbH (une filiale de Roivant Sciences Ltd) et coprésident et directeur des investissements chez Montes Archimedes Acquisition Corp. Au cours de sa carrière, M. Sukhatme a occupé les postes de directeur chez Hutchin Hill Capital LP, d'associé chez Apple Tree Partners, de gestionnaire de portefeuille chez Sio Capital Management LLC et de président d'Urovant Sciences Ltd. Le Dr Sukhatme a obtenu un diplôme de premier cycle au Massachusetts Institute of Technology et un doctorat à la Harvard Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ROIVANT SCIENCES LTD. 2,59 % | 30/06/2026 | 18 630 739 ( 2,59 % ) | 559 M $ | 31/05/2026 |
Postes actifs de Mayukh Sukhatme
| Sociétés | Poste | Début |
|---|---|---|
| ROIVANT SCIENCES LTD. | President | 01/01/2021 |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | President | 01/01/2015 |
Anciens postes connus de Mayukh Sukhatme
| Sociétés | Poste | Fin |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/08/2015 |
Apple Tree Venture Management Llc//vc
 Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | 01/01/2015 |
| ROIVANT SCIENCES LTD. | President | - |
| UROVANT SCIENCES LTD. | Président | - |
Hutchin Hill Capital LP
 Hutchin Hill Capital LP Investment ManagersFinance Hutchin Hill Capital employs a systematic, process-driven approach to investing in an array of highly-liquid asset classes and markets. Their investment approach includes both quantitative and fundamental strategies. Hutchin Hill Capital generally allocates capital across a broad and diverse array of strategic opportunities. The firm's Core strategies include Global Equities, Fundamental Long/Short Credit, Global Macro and, Systematic & Quantitative. They also offer a strategy that includes a custom convexity hedging program for the overall Diversified Alpha Master Fund that seeks to serve as a defense against major market dislocations, tail events and other risks not hedged within each of the four Core strategies. Hutchin Hill focuses on strategies that purchase and sell liquidly-traded instruments for which there is a generally active market (although the Diversified Alpha Master Fund may trade in illiquid instruments or markets that are not generally active). The firm purchases and sells a broad array of instruments within their strategies across a variety of asset classes using cash instruments and over-the counter derivatives and including equities, fixed income/interest rates, corporate credit, currencies, and other instruments. Equity investments may include common stock and listed options on US and non-US corporations, and equity equivalent instruments such as total return swaps, CFDs and various futures and options. Interest rate investments may include US treasuries and other government bonds and bond futures and options, interest rate swaps, swaptions, and deposit rate futures and options. Corporate credit investments may cash bonds, credit default swaps referencing single issuers, and credit default swaps related to credit indices (such as the CDX and iTraxx) and other fixed income securities. Currency transactions may include currency spot and forward transactions, NDFs, futures and options. The firm also invests in commodity futures, options, and swaps; and other instruments, including ETFs and derivatives, such as variance swaps and volatility swaps. | Corporate Officer/Principal | - |
Formation de Mayukh Sukhatme
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Sio Capital Management LLC
 Sio Capital Management LLC Investment ManagersFinance Sio Capital aims to invest capital in a global, healthcare-focused portfolio in order to generate attractive returns for their investors. The firm has a ‘value’ orientation with a strong attention to balance sheet quality and cash flow generation. Their long portfolios typically include growth at a reasonable price (GARP) and growth investments when attractive opportunities arise. For Sio Capital’s portfolios of short investments, they look for shorts that are ‘hyped up’ and whose valuations are predicated on expectations that the firm believes to be unattainable. | Finance |
Apple Tree Venture Management Llc//vc
Apple Tree Venture Management Llc//vc Investment ManagersFinance Apple Tree Partners invests in companies located in the United States. The firm focuses on the life sciences sector. It provides financing for seed, early and later stage capital requirements. | Finance |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hutchin Hill Capital LP
Hutchin Hill Capital LP Investment ManagersFinance Hutchin Hill Capital employs a systematic, process-driven approach to investing in an array of highly-liquid asset classes and markets. Their investment approach includes both quantitative and fundamental strategies. Hutchin Hill Capital generally allocates capital across a broad and diverse array of strategic opportunities. The firm's Core strategies include Global Equities, Fundamental Long/Short Credit, Global Macro and, Systematic & Quantitative. They also offer a strategy that includes a custom convexity hedging program for the overall Diversified Alpha Master Fund that seeks to serve as a defense against major market dislocations, tail events and other risks not hedged within each of the four Core strategies. Hutchin Hill focuses on strategies that purchase and sell liquidly-traded instruments for which there is a generally active market (although the Diversified Alpha Master Fund may trade in illiquid instruments or markets that are not generally active). The firm purchases and sells a broad array of instruments within their strategies across a variety of asset classes using cash instruments and over-the counter derivatives and including equities, fixed income/interest rates, corporate credit, currencies, and other instruments. Equity investments may include common stock and listed options on US and non-US corporations, and equity equivalent instruments such as total return swaps, CFDs and various futures and options. Interest rate investments may include US treasuries and other government bonds and bond futures and options, interest rate swaps, swaptions, and deposit rate futures and options. Corporate credit investments may cash bonds, credit default swaps referencing single issuers, and credit default swaps related to credit indices (such as the CDX and iTraxx) and other fixed income securities. Currency transactions may include currency spot and forward transactions, NDFs, futures and options. The firm also invests in commodity futures, options, and swaps; and other instruments, including ETFs and derivatives, such as variance swaps and volatility swaps. | Finance |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for urologic conditions | Health Technology |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Choisissez Zonebourse 
